Liposomal GHK-Cu accelerated scald wound healing in mice by boosting cell proliferation and angiogenesis
Background
The copper peptide Glycyl-l-histidyl-l-lysine (GHK-Cu) is known as an activator of tissue remodeling and is already utilized in cosmetic products for skin health. However, its therapeutic application in more severe injuries like scald wounds is an area of active investigation. Standard wound care can be slow and may result in scarring, creating a need for agents that can accelerate and improve the quality of healing. This study explores whether a novel delivery system—encapsulating GHK-Cu in nanoscaled liposomes—could enhance its therapeutic effects on skin regeneration, specifically by improving its impact on cell proliferation and the formation of new blood vessels (angiogenesis), which are critical processes for effective wound repair.
Study Design
The study used a dual approach. First, an in vitro model used human umbilical vein endothelial cells (HUVECs) to assess the effects of GHK-Cu-liposomes on cell growth. Proliferation rates were measured, and cell cycle progression was analyzed using flow cytometry. Protein expression of growth factors (VEGF, FGF-2) and cell cycle regulators (CDK4, CyclinD1) was quantified via Western blotting. Second, an in vivo scald wound model was established in mice. The animals were treated with either the GHK-Cu-liposome formulation or free GHK-Cu, and wound healing was monitored over time, with the primary endpoint being complete wound closure.
Results
The liposomal formulation of GHK-Cu significantly enhanced its biological activity. In the in vitro experiments, GHK-Cu-liposomes increased HUVEC proliferation by a rate of 33.1%. Flow cytometry data revealed this was associated with an increased number of cells in the G1 phase and a decreased number in the G2 phase of the cell cycle. This pro-proliferative effect was supported by Western blotting, which showed that the liposomal treatment enhanced the expression of key growth factors VEGF and FGF-2, as well as the cell cycle-related proteins CDK4 and CyclinD1.
In the mouse scald model, the liposomal formulation proved superior to free GHK-Cu, shortening the total wound healing time to just 14 days post-injury. Immunofluorescence analysis of the healed skin tissue confirmed enhanced biological activity, showing stronger signals for the angiogenesis marker
CD31and the proliferation markerKi67in the GHK-Cu-liposome treated group compared to the free GHK-Cu group.
Key Findings
- GHK-Cu-liposomes increased human umbilical vein endothelial cell (HUVEC) proliferation by 33.1%.
- In a mouse scald model, GHK-Cu-liposomes shortened wound healing time to 14 days.
- The liposomal formulation enhanced expression of growth factors VEGF and FGF-2.
- Expression of cell cycle proteins CDK4 and CyclinD1 was increased by GHK-Cu-liposome treatment.
- Immunofluorescence showed enhanced signals of angiogenesis (CD31) and proliferation (Ki67) markers in treated mice.
Why It Matters
This study highlights that the delivery method of a peptide can be as important as the peptide itself. For users of GHK-Cu, this suggests that liposomal or other advanced topical formulations may offer significantly better results for wound healing and tissue regeneration than standard solutions. The findings directly support the use of GHK-Cu-liposomes as a more effective treatment for skin wounds, particularly burns, by accelerating healing and improving key biological processes like angiogenesis. While this is an animal study, it provides a strong preclinical basis for developing advanced GHK-Cu topical products for clinical use. The enhanced expression of VEGF and FGF-2 also points to a broader applicability in regenerative protocols where promoting blood vessel growth is beneficial.
TitrateLab articles covering GHK-Cu
Written by TitrateLab, separately from the study summarized above.
